What is the most profitable pharmaceutical drug ever?

The Billion-Dollar Pill: How Lipitor Became the Most Profitable Drug Ever

Lipitor, the cholesterol-lowering statin developed by Warner-Lambert and later marketed by Pfizer, stands as the most profitable pharmaceutical drug in history. With a staggering $94.67 billion in cumulative sales in the United States alone, its financial success is unmatched.

Approved by the FDA in December 1996, Lipitor wasn’t the first statin on the market—but it quickly outpaced its competitors. Its rise was fueled by aggressive marketing, strong clinical data showing effectiveness in reducing LDL cholesterol, and widespread physician adoption. As cardiovascular disease became a leading health concern worldwide, Lipitor positioned itself as a go-to preventive treatment for millions.

Pfizer acquired Warner-Lambert in 2000, a move largely driven by Lipitor’s explosive growth. At its peak in the early 2000s, the drug was generating over $13 billion in annual sales, making it the top-selling medication globally for several years. Its success wasn’t just in chemistry—it was also a masterclass in branding and market strategy.

Despite the eventual expiration of its patent in 2011, which opened the door for generic versions and sharply reduced revenue, Lipitor’s legacy endures. It reshaped how pharmaceutical companies approach blockbuster drugs, proving that a well-marketed medication for a chronic, widespread condition could achieve unprecedented commercial heights.

While newer drugs in areas like oncology and biologics are now breaking sales records, none have yet surpassed Lipitor’s total earnings. It remains a benchmark in the industry—not just for its molecular impact, but for its monumental financial footprint.